Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
American Journal of Hypertension
|
July 6, 2004
Adrenal medullary overactivity in lean, borderline hypertensive young men
Henrik M Reims, Eigil Fossum, Aud Høieggen, et al.
Metabolism: Clinical and Experimental
|
October 24, 2007
Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity
Tonje Amb Aksnes, Ingebjörg Seljeflot, Peter A Torjesen, et al.
Blood Pressure
|
June 9, 2004
High screening blood pressure is related to sympathetic nervous system activity and insulin resistance in healthy young men
Eigil Fossum, Aud Høieggen, Henrik M Reims, et al.
Journal of the American College of Cardiology
|
September 6, 2005
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study
Eigil Fossum, Andreas Moan, Sverre E Kjeldsen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
American Journal of Hypertension
|
July 6, 2004
Adrenal medullary overactivity in lean, borderline hypertensive young men
Henrik M Reims, Eigil Fossum, Aud Høieggen, et al.
Metabolism: Clinical and Experimental
|
October 24, 2007
Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity
Tonje Amb Aksnes, Ingebjörg Seljeflot, Peter A Torjesen, et al.
Blood Pressure
|
June 9, 2004
High screening blood pressure is related to sympathetic nervous system activity and insulin resistance in healthy young men
Eigil Fossum, Aud Høieggen, Henrik M Reims, et al.
Journal of the American College of Cardiology
|
September 6, 2005
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study
Eigil Fossum, Andreas Moan, Sverre E Kjeldsen, et al.
Page
of 1